Literature DB >> 21184148

The effect of human bone marrow stroma-derived heparan sulfate on the ex vivo expansion of human cord blood hematopoietic stem cells.

Diah S Bramono1, David A Rider, Sadasivam Murali, Victor Nurcombe, Simon M Cool.   

Abstract

PURPOSE: In order to address cell dose limitations associated with the use of cord blood hematopoietic stem cell (HSC) transplantation, we explored the effect of bone marrow stroma-derived heparan sulfate (HS) on the ex vivo expansion of HSCs.
METHODS: Heparan sulfate was isolated and purified from the conditioned media of human bone marrow stromal cells and used for the expansion of cord blood-derived CD34(+) cells in the presence of a cocktail of cytokines.
RESULTS: The number of myeloid lineage-committed progenitor cells was increased at low dosage of HS as illustrated by an increase in the total number of colony-forming cells (CFC) and colonies of erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) precursors. Notably, the stroma-derived HS did not alter the growth of CD34(+) HSCs or negatively affect the levels of various HSC phenotypic markers after expansion.
CONCLUSIONS: This study shows that HS secreted into solution by stromal cells has the capacity to support hematopoietic cytokines in the maintenance and expansion of HSCs. The incorporation of stroma-derived HS as a reagent may improve the efficacy of cord blood HSC transplantation by enhancing the number of committed cells and accelerating the rate of engraftment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21184148     DOI: 10.1007/s11095-010-0352-y

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  41 in total

1.  Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System.

Authors:  Jennifer Jaroscak; Kristin Goltry; Alan Smith; Barbara Waters-Pick; Paul L Martin; Timothy A Driscoll; Richard Howrey; Nelson Chao; Judy Douville; Sue Burhop; Pingfu Fu; Joanne Kurtzberg
Journal:  Blood       Date:  2003-02-20       Impact factor: 22.113

2.  Expansion of CD34+ cells on telomerized human stromal cells without losing erythroid-differentiation potential in a serum-free condition.

Authors:  Masayoshi Kobune; Yutaka Kawano; Junji Kato; Yoshinori Ito; Hiroki Chiba; Kiminori Nakamura; Akihito Fujimi; Takuya Matsunaga; Hirofumi Hamada; Yoshiro Niitsu
Journal:  Int J Hematol       Date:  2005-01       Impact factor: 2.490

3.  Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4.

Authors:  A Peled; I Petit; O Kollet; M Magid; T Ponomaryov; T Byk; A Nagler; H Ben-Hur; A Many; L Shultz; O Lider; R Alon; D Zipori; T Lapidot
Journal:  Science       Date:  1999-02-05       Impact factor: 47.728

Review 4.  CD34: structure, biology, and clinical utility.

Authors:  D S Krause; M J Fackler; C I Civin; W S May
Journal:  Blood       Date:  1996-01-01       Impact factor: 22.113

5.  Purification and characterization of heparan sulfate from human primary osteoblasts.

Authors:  Sadasivam Murali; Kerry J Manton; Vinalia Tjong; Xiaodi Su; Larisa M Haupt; Simon M Cool; Victor Nurcombe
Journal:  J Cell Biochem       Date:  2009-12-01       Impact factor: 4.429

6.  Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution.

Authors:  Colleen Delaney; Shelly Heimfeld; Carolyn Brashem-Stein; Howard Voorhies; Ronald L Manger; Irwin D Bernstein
Journal:  Nat Med       Date:  2010-01-17       Impact factor: 53.440

7.  Transplantation of ex vivo expanded cord blood.

Authors:  Elizabeth J Shpall; Ralph Quinones; Roger Giller; Chan Zeng; Anna E Baron; Roy B Jones; Scott I Bearman; Yago Nieto; Brian Freed; Nancy Madinger; Christopher J Hogan; Vicki Slat-Vasquez; Peggy Russell; Betsy Blunk; Deborah Schissel; Elaine Hild; Janet Malcolm; William Ward; Ian K McNiece
Journal:  Biol Blood Marrow Transplant       Date:  2002       Impact factor: 5.742

8.  Heparan sulfate mediates the proliferation and differentiation of rat mesenchymal stem cells.

Authors:  Christian Dombrowski; Shu Jun Song; Peiying Chuan; Xinhong Lim; Evelyn Susanto; Amber A Sawyer; Maria A Woodruff; Dietmar W Hutmacher; Victor Nurcombe; Simon M Cool
Journal:  Stem Cells Dev       Date:  2009-05       Impact factor: 3.272

9.  Flt3 ligand induces proliferation of quiescent human bone marrow CD34+CD38- cells and maintains progenitor cells in vitro.

Authors:  A J Shah; E M Smogorzewska; C Hannum; G M Crooks
Journal:  Blood       Date:  1996-05-01       Impact factor: 22.113

10.  Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin.

Authors:  Wei Li; Daniel J D Johnson; Charles T Esmon; James A Huntington
Journal:  Nat Struct Mol Biol       Date:  2004-08-15       Impact factor: 15.369

View more
  7 in total

1.  Effect of heparin on the biological properties and molecular signature of human mesenchymal stem cells.

Authors:  Ling Ling; Emily T Camilleri; Torben Helledie; Rebekah M Samsonraj; Drew M Titmarsh; Ren Jie Chua; Oliver Dreesen; Christian Dombrowski; David A Rider; Mario Galindo; Ian Lee; Wanjin Hong; James H Hui; Victor Nurcombe; Andre J van Wijnen; Simon M Cool
Journal:  Gene       Date:  2015-10-17       Impact factor: 3.688

2.  Heparan sulfate mimetics can efficiently mobilize long-term hematopoietic stem cells.

Authors:  Fabio Di Giacomo; Daniel Lewandowski; Eric Cabannes; Vanessa Nancy-Portebois; Maurice Petitou; Serge Fichelson; Paul-Henri Romeo
Journal:  Haematologica       Date:  2011-12-16       Impact factor: 9.941

3.  Bone marrow-derived heparan sulfate potentiates the osteogenic activity of bone morphogenetic protein-2 (BMP-2).

Authors:  Diah S Bramono; Sadasivam Murali; Bina Rai; Ling Ling; Wei Theng Poh; Zophia Xuehui Lim; Gary S Stein; Victor Nurcombe; Andre J van Wijnen; Simon M Cool
Journal:  Bone       Date:  2011-12-28       Impact factor: 4.398

Review 4.  Heparan Sulfate Proteoglycans: Key Mediators of Stem Cell Function.

Authors:  Maanasa Ravikumar; Raymond Alexander Alfred Smith; Victor Nurcombe; Simon M Cool
Journal:  Front Cell Dev Biol       Date:  2020-11-19

Review 5.  Proteoglycans and Glycosaminoglycans in Stem Cell Homeostasis and Bone Tissue Regeneration.

Authors:  Jiawen Chen; Tianyu Sun; Yan You; Buling Wu; Xiaofang Wang; Jingyi Wu
Journal:  Front Cell Dev Biol       Date:  2021-11-30

6.  Neoplastic bone marrow niche: hematopoietic and mesenchymal stem cells.

Authors:  Najmaldin Saki; Saeid Abroun; Majid Farshdousti Hagh; Farahnaz Asgharei
Journal:  Cell J       Date:  2011-09-23       Impact factor: 2.479

7.  In vitro and in vivo evaluation of cord blood hematopoietic stem and progenitor cells amplified with glycosaminoglycan mimetic.

Authors:  Lionel Faivre; Véronique Parietti; Fernando Siñeriz; Sandrine Chantepie; Marie Gilbert-Sirieix; Patricia Albanese; Jérôme Larghero; Valérie Vanneaux
Journal:  Stem Cell Res Ther       Date:  2016-01-07       Impact factor: 6.832

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.